NCT02245737 An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Status TERMINATED Phase PHASE2/PHASE3
NCT02242981 A Study of How the Body Breaks Down and Eliminates LY2623091 Status COMPLETED Phase PHASE1
NCT02240433 A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) Status COMPLETED Phase PHASE1
NCT02230995 Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02227784 A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Status TERMINATED Phase PHASE3
NCT02224846 A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction Status COMPLETED Phase PHASE4
NCT02197520 A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics Status COMPLETED Phase PHASE1
NCT02197078 Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin Status COMPLETED Phase N/A
NCT02194465 A Study of LY2623091 in Participants With High Blood Pressure Status COMPLETED Phase PHASE2
NCT02192190 A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain Status TERMINATED Phase PHASE2
NCT02188693 Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast Cancer Status UNKNOWN Phase N/A
NCT02182830 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension Status COMPLETED Phase PHASE3
NCT02181101 Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial Status COMPLETED Phase PHASE3
NCT02178358 A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2